⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4472556 | 1.00 | — | — | |
| SCHEMBL4490657 | 1.00 | — | — | |
| SCHEMBL9430058 | 0.86 | — | — | |
| SCHEMBL10087473 | 0.86 | — | — | |
| SCHEMBL20395109 | 0.82 | — | — | |
| SCHEMBL7901480 | 0.78 | — | — | |
| SCHEMBL14639046 | 0.78 | — | — | |
| SCHEMBL971556 | 0.78 | — | — | |
| SCHEMBL7903270 | 0.78 | — | — | |
| SCHEMBL7161641 | 0.76 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 24 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-4031115-A | 4-PENTENOIC ACID, AIR, OXYGEN, CATALYST | CHEVRON RESEARCH COMPANY (US) | 1977-06-21 | — | — | US | claimed |
| US-12031030-B2 | Process for preparing a sulfur copolymer | BASF SE (DE) | 2024-07-09 | — | — | US | disclosed |
| CN-109970743-B | 5-chloro-2-difluoromethoxyphenyl pyrazolopyrimidine compounds as JAK inhibitors | 豪夫迈·罗氏有限公司 | 2022-03-04 | — | — | CN | disclosed |
| US-11161987-B2 | Mixed transition metal oxides silica xerogels as antifouling/fouling release surfaces | THE RESEARCH FOUNDATION FOR THE STATE UNIVERSITY OF NEW YORK (US) | 2021-11-02 | — | — | US | disclosed |
| EP-3145929-B1 | 5-CHLORO-2-DIFLUOROMETHOXYPHENYL PYRAZOLOPYRIMIDINE COMPOUNDS WHICH ARE JAK INHIBITORS | HOFFMANN LA ROCHE (CH) | 2021-01-13 | — | — | EP | disclosed |
| US-20190322661-A1 | 5-CHLORO-2-DIFLUOROMETHOXYPHENYL PYRAZOLOPYRIMIDINE COMPOUNDS,COMPOSITIONS AND METHODS OF USE THEREOF | GENENTECH, INC. (US) | 2019-10-24 | — | — | US | disclosed |
| US-20180362778-A1 | MIXED TRANSITION METAL OXIDES SILICA XEROGELS AS ANTIFOULING/FOULING RELEASE SURFACES | THE RESEARCH FOUNDATION FOR THE STATE UNIVERSITY OF NEW YORK (US) | 2018-12-20 | — | — | US | disclosed |
| US-20180305355-A1 | 5-CHLORO-2-DIFLUOROMETHOXYPHENYL PYRAZOLOPYRIMIDINE COMPOUNDS,COMPOSITIONS AND METHODS OF USE THEREOF | GENENTECH, INC. (US) | 2018-10-25 | — | — | US | disclosed |
| WO-2017100629-A1 | MIXED TRANSITION METAL OXIDES SILICA XEROGELS AS ANTIFOULING/FOULING RELEASE SURFACES | THE RESEARCH FOUNDATION FOR THE STATE UNIVERSITY OF NEW YORK (US) | 2017-06-15 | — | — | WO | disclosed |
| US-20170145020-A1 | 5-CHLORO-2-DIFLUOROMETHOXYPHENYL PYRAZOLOPYRIMIDINE COMPOUNDS,COMPOSITIONS AND METHODS OF USE THEREOF | GENENTECH, INC. (US) | 2017-05-25 | — | — | US | disclosed |
| US-20150336962-A1 | 5-CHLORO-2-DIFLUOROMETHOXYPHENYL PYRAZOLOPYRIMIDINE COMPOUNDS, COMPOSITIONS AND METHODS OF USE THEREOF | GENENTECH, INC. (US) | 2015-11-26 | — | — | US | disclosed |
| WO-2015177326-A1 | 5-CHLORO-2-DIFLUOROMETHOXYPHENYL PYRAZOLOPYRIMIDINE COMPOUNDS WHICH ARE JAK INHIBITORS | F. HOFFMANN-LA ROCHE AG (CH) | 2015-11-26 | — | — | WO | disclosed |
| US-7612106-B2 | Fused pyrazole derivatives and methods of treatment of metabolic-related disorders thereof | ARENA PHARMACEUTICALS, INC. (US) | 2009-11-03 | — | — | US | disclosed |
| US-20090258892-A1 | FUSED PYRAZOLE DERIVATIVES AND METHODS OF TREATMENT OF METABOLIC-RELATED DISORDERS THEREOF | ARENA PHARMACEUTICALS, INC. (US) | 2009-10-15 | — | — | US | disclosed |
| US-7241792-B2 | Fused pyrazole derivatives and methods of treatment of metabolic-related disorders thereof | ARENA PHARMACEUTICALS, INC. (US) | 2007-07-10 | — | — | US | disclosed |
| US-20070073062-A1 | Fused pyrazole derivatives and methods of treatment of metabolic-related disorders thereof | ARENA PHARMACEUTICALS, INC. | 2007-03-29 | — | — | US | disclosed |
| US-20060205955-A1 | Fused pyrazole derivatives and methods of treatment of metabolic-related disorders thereof | ARENA PHARMACEUTICALS, INC. (US) | 2006-09-14 | — | — | US | disclosed |
| US-4413133-A | Process for manufacturing chlorolactones from unsaturated carboxylic acids | INSTITUT FRANCAIS DU PETROLE (FR) | 1983-11-01 | — | — | US | disclosed |
| US-4031115-A | 4-PENTENOIC ACID, AIR, OXYGEN, CATALYST | CHEVRON RESEARCH COMPANY (US) | 1977-06-21 | — | — | US | disclosed |
| US-4031115-A | 4-PENTENOIC ACID, AIR, OXYGEN, CATALYST | CHEVRON RESEARCH COMPANY (US) | 1977-06-21 | — | — | US | disclosed |